SCHEMBL8943385

SCHEMBL8943385

OP(O)CP(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11417955 0.62
SCHEMBL340276 0.59
SCHEMBL11045275 0.59
SCHEMBL31520155 0.56
SCHEMBL31520152 0.56
SCHEMBL10525209 0.53
SCHEMBL6337 0.53
SCHEMBL574380 0.53
SCHEMBL8442506 0.53
Propane SCHEMBL23930374 0.50 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5534157-A PREVENTING CALCIUM SULFITE SCALE, FLUE GAS SCRUBBER SYSTEMS CALGON CORPORATION (US) 1996-07-09 US claimed
US-20170096691-A1 SELECTIVE ADVANTAGE IN FERMENTATION NOVOGY, INC. (US) 2017-04-06 US disclosed
US-20160215274-A1 MICROORGANISMS ENGINEERED TO USE UNCONVENTIONAL SOURCES OF PHOSPHOROUS OR SULFUR GINKGO BIOWORKS, INC. 2016-07-28 US disclosed
US-20080317834-A1 Compounds and methods for modulating cerebral amyloid angiopathy NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2008-12-25 US disclosed
US-20070078082-A1 Methods and compositions to treat glycosaminoglycan-associated molecular interactions NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-04-05 US disclosed